These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 25891086

  • 21. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
    Chang TC, Chiou WC, Lai WH, Huang HC, Huang YL, Liu HK, Liang YC, Huang C.
    Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
    [Abstract] [Full Text] [Related]

  • 22. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L.
    Biol Pharm Bull; 2015 Jan; 38(5):694-702. PubMed ID: 25947915
    [Abstract] [Full Text] [Related]

  • 23. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 24. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA, Hwang YJ, Kim GR, Choe JS.
    BMC Complement Altern Med; 2015 Oct 05; 15():347. PubMed ID: 26438035
    [Abstract] [Full Text] [Related]

  • 25. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS, Chen WC, Kuo TC, Ho CT, Kuo CH, Tseng YJ, Lu KH, Lin SH, Panyod S, Sheen LY.
    J Agric Food Chem; 2015 Sep 09; 63(35):7873-84. PubMed ID: 26262841
    [Abstract] [Full Text] [Related]

  • 26. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C, Tsuchiya K, Shiba K, Miyachi Y, Furuke S, Shimazu N, Yamaguchi S, Kanno K, Ogawa Y.
    PLoS One; 2016 Sep 09; 11(3):e0151511. PubMed ID: 26977813
    [Abstract] [Full Text] [Related]

  • 27. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A, Neschen S, Rozman J, Rathkolb B, Aichler M, Feuchtinger A, Brachthäuser L, Neff F, Kovarova M, Wolf E, Fuchs H, Häring HU, Peter A, Hrabě de Angelis M.
    Mol Metab; 2017 Mar 09; 6(3):256-266. PubMed ID: 28271032
    [Abstract] [Full Text] [Related]

  • 28. Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction.
    Jang HJ, Ridgeway SD, Kim JA.
    Am J Physiol Endocrinol Metab; 2013 Dec 09; 305(12):E1444-51. PubMed ID: 24148349
    [Abstract] [Full Text] [Related]

  • 29. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
    Coia H, Ma N, Hou Y, Permaul E, Berry DL, Cruz MI, Pannkuk E, Girgis M, Zhu Z, Lee Y, Rodriquez O, Cheema A, Chung FL.
    Clin Nutr; 2021 Jan 09; 40(1):110-119. PubMed ID: 32439267
    [Abstract] [Full Text] [Related]

  • 30. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
    Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS.
    J Nutr; 2008 Sep 09; 138(9):1677-83. PubMed ID: 18716169
    [Abstract] [Full Text] [Related]

  • 31. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
    Saad ZA, Khodeer DM, Zaitone SA, Ahmed AAM, Moustafa YM.
    Life Sci; 2020 Jul 15; 253():117725. PubMed ID: 32348835
    [Abstract] [Full Text] [Related]

  • 32. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
    Friedrich M, Petzke KJ, Raederstorff D, Wolfram S, Klaus S.
    Int J Obes (Lond); 2012 May 15; 36(5):735-43. PubMed ID: 21750518
    [Abstract] [Full Text] [Related]

  • 33. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet.
    Cao Y, Bao S, Yang W, Zhang J, Li L, Shan Z, Teng W.
    Nutr Res; 2014 Dec 15; 34(12):1066-74. PubMed ID: 25453543
    [Abstract] [Full Text] [Related]

  • 34. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS, Kim CT, Kim Y.
    Ann Nutr Metab; 2009 Dec 15; 54(2):151-7. PubMed ID: 19390166
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
    Zhang L, Yang B, Yu B.
    Biol Pharm Bull; 2015 Dec 15; 38(7):1005-11. PubMed ID: 25972092
    [Abstract] [Full Text] [Related]

  • 37. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.
    Liu B, Zhang J, Sun P, Yi R, Han X, Zhao X.
    Biomolecules; 2019 Sep 01; 9(9):. PubMed ID: 31480575
    [Abstract] [Full Text] [Related]

  • 38. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R, Lu CK, Nguyen HM, Hsiao HH, Chen CJ, Hsiao HP, Lin KJ, Fang CC, Yen CH.
    Biomed Pharmacother; 2020 Sep 01; 129():110348. PubMed ID: 32554245
    [Abstract] [Full Text] [Related]

  • 39. Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity.
    Sampath C, Rashid MR, Sang S, Ahmedna M.
    Biomed Pharmacother; 2017 Mar 01; 87():73-81. PubMed ID: 28040599
    [Abstract] [Full Text] [Related]

  • 40. Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms.
    Yan Z, Fan R, Yin S, Zhao X, Liu J, Li L, Zhang W, Ge L.
    Int J Biol Macromol; 2015 Sep 01; 80():573-80. PubMed ID: 26047899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.